Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/rheumatology/kez662 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Treatment of Acne Vulgaris With a 650-ms, 1064-nm Nd:YAG Laser: A Retrospective Study.
J Cosmet Dermatol
December 2024
Vibrant Dermatology, Dedham, Massachusetts, USA.
Background: The 650-ms, 1064-nm Nd:YAG laser device may provide superior efficacy and tolerability for the treatment of acne vulgaris over conventional treatments.
Aim: To evaluate the efficacy and tolerability of a 650-ms laser for the treatment of mild to severe facial acne vulgaris.
Patients/methods: Records of 225 subjects with mild to severe facial acne vulgaris and treated with a 650-ms laser were reviewed.
Outcome of Glomerular Disease Manifesting After Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
Cureus
July 2024
Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, IND.
Introduction Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can upregulate the immune system and may contribute to glomerular disease (GD). Here, we describe a spectrum of GD that manifested following vaccination against SARS-CoV-2 (COVID-19 vaccinations). Material and methods This was a descriptive study of 10 cases enrolled between January 2021 and January 2023.
View Article and Find Full Text PDFTopical moisturizer with rose stem cell-derived exosomes (RSCEs) for recalcitrant seborrheic dermatitis: A case report with 6 months of follow-up.
J Cosmet Dermatol
October 2024
Department of Pediatrics, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Pathum Wan, Bangkok, Thailand.
Introduction: Seborrheic dermatitis (SD) poses significant treatment challenges due to its chronic nature and the side effects associated with long-term use of conventional therapies like topical corticosteroids. In the search for alternative treatments, exosomes, particularly those derived from rose stem cells (RSCEs), offer a promising avenue due to their potential in managing chronic skin conditions.
Objective: This case report examines the efficacy of a topical moisturizer containing RSCEs in treating a patient with refractory SD, aiming to provide an alternative treatment pathway.
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.
Vaccines (Basel)
April 2024
Department of Dermatology, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan 33305, Taiwan.
Article Synopsis
- Autoimmune bullous dermatosis (AIBD) cases have been observed in patients after receiving COVID-19 vaccinations, prompting a systematic review of their characteristics and outcomes.
- The review analyzed 98 studies involving 229 new-onset AIBD cases (mostly bullous pemphigoid) and 216 flare cases (predominantly pemphigus), with mRNA vaccines being a common link.
- Most AIBD cases emerged within 1 to 123 days after vaccination, with many patients experiencing favorable outcomes, highlighting the need for healthcare professionals to monitor post-vaccination effects carefully.
Altered serum antibody levels in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis.
Arch Rheumatol
March 2024
Department of Pediatrics, Near East University, Nicosia, Cyprus.
Objectives: This study aimed to extend the literature by analyzing immunoglobulin (Ig) A, IgE, IgG, IgG2, IgG3, and IgM antibody levels in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) patients.
Patients And Methods: This study retrospectively analyzed the antibody test results of 20 pediatric patients (10 males, 10 females; mean age: 2.5±1.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!